Transparency
Market Research Report Added “Global
and China Insulin Market (Rapid-Acting, Short-Acting,
Intermediate-Acting, Long-Acting, Premixed, Modern and Human
Insulin)"
to its database.
Global
and China Insulin Market:Overview
The
research report states that the global and China insulin market is
expected to grow at a CAGR of 6.10% between 2013 and 2019 to reach
US$32.2 bn by the end of 2019, from US$19.9 bn in 2012. The global
and China insulin market is segmented on the basis of mode of action
and source. The modes of action seen in the insulin market are
rapid-acting, long-acting, short-acting, intermediate-acting, and
premixed. On the other hand, the sources of insulin are human insulin
and modern insulin.
Amongst
the types of insulin, the long-lasting insulin segment is expected to
grow at a CAGR of 8.70% in the forecast period. This mode of action
for managing sugar levels will be popular amongst insulin-dependent
diabetics, as only a small dosage is required to bring down blood
glucose. Additionally, relatively relaxed regulations regarding the
pricing of long-lasting insulin and availability of a wide range of
products will also foster the growth of this segment in the overall
insulin market.
In
2012, the rapid-acting insulin segment was at the second position in
the overall market. In the same period, the premixed insulin segment
held a market share of over 50% in the global and China insulin
market. In the foreseeable future, intermediate-acting and
short-acting insulin are expected to lose ground, as diabetics are
shifting preferences and neither of these types of insulin are
supported by adequate research and development channels.
Browse
Market Research
Report:
http://www.transparencymarketresearch.com/insulin-market.html
http://www.transparencymarketresearch.com/insulin-market.html
Diabetes
is a chronic metabolic disorder wherein the body is either unable to
produce insulin (glucose digesting hormone) or unable to utilize the
produced insulin to metabolize blood glucose. This condition results
in increased blood glucose level, which leads to various chronic and
life-threatening diseases. Insulin is a hormone secreted by β-cells
of pancreas in order to metabolize the blood sugar. The insulin
market is a rapidly growing market. Demand for premixed and
long-acting insulin derivatives is growing rapidly due to rising
incidences of type 1 diabetes. This report focuses on identifying the
current scenario as well as the future market potential for insulin
globally. Additionally, the insulin market in China is also analyzed
and studied thoroughly. The insulin market is segmented based on two
important parameters: by mode of action and by source. By mode of
action, the market (global and China) is categorized as rapid-acting,
short-acting, intermediate-acting, long-acting and premixed insulin
derivatives. Furthermore, by source, the market is categorized as
human insulin and modern insulin.
Long-acting
insulin derivatives is projected to be the fastest growing segment,
expanding at a CAGR of 8.7% during the forecast period from 2013 to
2019. According to the World Health Organization (WHO), more than 366
million people worldwide were diagnosed with diabetes in 2011 and an
additional 280 million are expected to be diagnosed over the next 20
years. Majority of these patients are likely to be from emerging
markets such as China and India.
Rising
demand for long-acting insulin derivatives is attributed to
advantages such as reduced number of doses compared to other
derivatives. Moreover, strong pipeline, lack of stringent regulations
on price capping and high entry barriers for biosimilar manufacturers
are other important growth drivers in the market. The market for
modern insulin is also expected to increase during the forecast
period from 2013 to 2019 due to various factors such as
ease-of-administration and higher efficacy.
Fill
the form for an exclusive sample of this
report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=259
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=259
Global
and China insulin market is segmented on the basis of geography as
follows:
- North America
- Europe
- Asia Pacific
- Rest of the World (RoW)
This
report gives you access to decisive data such as:
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for the coming years
Key
highlights of this report
- Overview of key market forces propelling and restraining market growth
- Up-to-date analyses of market trends and technological improvements
- Pin-point analyses of market competition dynamics to offer you a competitive edge
- An analysis of strategies of major competitors
- An array of graphics and SWOT analysis of major industry segments
- Detailed analyses of industry trends
- A well-defined technological growth map with an impact-analysis
- Offers a clear understanding of the competitive landscape and key product segments
No comments:
Post a Comment